TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
HRMY

Harmony Biosciences Holdings

Healthcare · Biotechnology

42.10$ +0.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow HRMY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
+46.6% +51.9% +0.2% +58.4%
+1,966.3% +169.3% +105.9% +18.8% -2.8% -1.0% +5.1%
+818.4% -52.6% +243.2% +67.1% +17.8% +34.4% +5.4%
+5,872.8% -48.9% +28.3% -237.9%
-442.6% -415.2% -120.9%
-88.9% +1,243.6% -85.1% -42.3% +81.4% +269.6% -73.1%
+9,374.6% -98.4% +4,909.9% +41.4% -67.3% +45.3% -41.2%
+39.3%
-64.6% -85.2% -77.4% -1,231.1% -100.0%
+0.0% -2.5% -100.5% +300.0% -37.5% +1,100.0% +8.3%
+565.1% +45.5% -96.5% -7.8% -1,642.9% -89.6% -17.7%
-97.2% +66.9% +611.3% +109.7% +111.9%
+46.9% +51.8% -0.2% +59.1%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?